Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 04, 2025
Ardena announced that it has successfully completed the acquisition of Catalent’s state-of-the-art drug product manufacturing facility in Somerset, New Jersey.
read more
Tuesday, February 04, 2025
Jabil Inc. announced the acquisition of Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) specializing in early stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid...
read more
Tuesday, February 04, 2025
Eleva and 3PBIOVIAN announced a strategic alliance to collaborate on the manufacturing of current pipeline programs and potential future programs based on Eleva’s technology platform.
read more
Tuesday, February 04, 2025
HealthTech BioActives (HTBA) announced the completion of a €25 million investment project to modernize its research, development and manufacturing center in Murcia, Spain.
read more
Monday, February 03, 2025
The new facilities, located in Raleigh, USA, Lelystad, Netherlands, and Dublin, Ireland, reflect Uniphar’s commitment to enhancing its logistics and distribution capabilities within global pharmaceutical and healthcare sectors.
read more
Thursday, January 30, 2025
miRecule and GBI Biomanufacturing announced a strategic partnership to advance the development and clinical supply of miRecule's innovative Antibody-RNA Conjugate (ARC) based products.
read more
Thursday, January 30, 2025
Atreo, Inc. has announced a strategic preferred partnership with N-SIDE. This collaboration aims to empower pharmaceutical and biotech companies with seamlessly integrated solutions, enabling faster drug development and improved operational ...
read more
Wednesday, January 29, 2025
Kenox Pharmaceuticals Inc. announced the addition of small scale non-sterile GMP capabilities to support GLP pre-clinical studies to its comprehensive suite of drug development services.
read more
Wednesday, January 29, 2025
Upperton Pharma Solutions has completed the build of its new sterile manufacturing facility in Nottingham, UK.
read more
Tuesday, January 28, 2025
Conduit Pharmaceuticals Inc. announced the completion of the first phase of its strategic collaboration with Sarborg Limited. This partnership was initiated in December 2024 to integrate an advanced artificial intelligence and cybernetics technology ...
read more
Tuesday, January 28, 2025
Under this partnership, Cellipont Bioservices will provide technology transfer, analytical method transfer, and cGMP manufacturing for the STM-01 Master Cell Bank. STM-01, a novel nCPC product, is protected under a recently issued composition of ...
read more
Tuesday, January 28, 2025
Lantheus Holdings, Inc. announced a definitive agreement to acquire Evergreen Theragnostics, Inc., in an all-cash transaction consisting of an upfront payment of $250 million and up to an additional $752.5 million in potential milestone payments.
read more
Tuesday, January 28, 2025
Sapio Sciences announced that Schrödinge has adopted the Sapio Platform to improve data management, enhance lab efficiency, and accelerate the discovery of novel molecules.
read more
Thursday, January 23, 2025
SGS announced the launch of Germany’s first commercial cell sorting service via fluorescent-activated cell sorting (FACS) for the biopharmaceutical industry.
read more
Thursday, January 23, 2025
Polyrizon Ltd. has commenced preliminary work related to the Good Manufacturing Practice (GMP) manufacturing process for its PL-14 allergy blocker in preparation for its planned 2025 clinical trial. The company works closely with Eurofins CDMO, ...
read more